Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Japanese regulators grant additional approval for the sale of Ipsen's rare cancer drug in Japan

biospectrumasiaNovember 16, 2018

Tag: Ipsen , CLARINET , Somatuline

PharmaSources Customer Service